Brainsway Surges Most in Five Years on Depression Trial Results

April 17 (Bloomberg) -- Brainsway Ltd. surged the most in more than five years after the maker of devices to treat neurological disorders said trial results of its Deep TMS treatment showed a significant drop in depression.

The shares gained 37 percent, the biggest intraday jump since January 2007 when Bloomberg started tracking the data, to 27.65 shekels at 11:09 a.m. in Tel Aviv.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net